A bee collects pollen from a sunflower in a field on the outskirts of Frankfurt, Germany, Friday, Aug. 2, 2024. (AP Photo/Michael Probst)
Meet neffy: Health Canada approves epinephrine nasal spray for anaphylaxis
Apr 15, 2026 | 11:26 AM
-
Share on Facebook
-
Share on Bluesky
-
Share on X
- Copy Link
TORONTO — Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called neffy.
ALK Canada, which purchased the rights to distribute the drug, says the two-milligram treatment has been approved for adults and pediatric patients who weigh at least 30 kilograms — roughly 66 lbs.
It says the spray could be on the market as soon as this summer.
As it stands, epinephrine auto-injectors — known by the brand name EpiPen — are the only emergency treatment option available for allergic reactions.
